GB Patent

GB202103807D0 — A crystalline salt of edaravone, processes for the preparation and use thereof

Assigned to Johnson Matthey PLC · Expires 2021-05-05 · 5y expired

What this patent protects

Patent listed against Radicava.

Drugs covered by this patent

Patent Metadata

Patent number
GB202103807D0
Jurisdiction
GB
Classification
—
Expires
2021-05-05
Drug substance claim
No
Drug product claim
No
Assignee
Johnson Matthey PLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.